Literature DB >> 186003

Equine herpesviruses: type 3 as an abortigenic agent.

L J Gleeson, N D Sullivan, M J Studdert.   

Abstract

The inoculation of equine herpesvirus type 3 (EHV3) strain 65/61 into the amniotic cavity of a mare 6-7 months pregnant resulted in abortion 11 days later. Following abortion typical lesions of coital exanthema were not observed in the genital tract of the mare, nor was EHV3 isolated from her. Serological evidence, however, indicated that the mare was infected with EHV3 following inoculation. Grossly the foetal disease was characterised by placentitis, focal ulcerative dermatitis, focal necrosis of the lungs and a striking diptheritic gastritis. Histological findings were interstitial pneumonia, diffuse hepatitis, generalised myositis, extensive vascular necrosis and degeneration of a range of epithelial cells. EHV3 was isolated from the placenta and placental fluids, stomach fluid, pooled thoracic and abdominal fluid, skin, lung, spleen and small intestine of the foetus.

Entities:  

Mesh:

Year:  1976        PMID: 186003     DOI: 10.1111/j.1751-0813.1976.tb09485.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  3 in total

1.  Role of equine herpesviruses as co-infecting agents in cases of abortion, placental disease and neonatal foal mortality.

Authors:  Maria Luisa Marenzoni; Annalisa Bietta; Elvio Lepri; Patrizia Casagrande Proietti; Paolo Cordioli; Elena Canelli; Valentina Stefanetti; Mauro Coletti; Peter J Timoney; Fabrizio Passamonti
Journal:  Vet Res Commun       Date:  2013-09-20       Impact factor: 2.459

2.  Analysis of small and large plaque variants of equine herpesvirus type 3 by restriction endonucleases. Brief report.

Authors:  M Kamada; M J Studdert
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1.

Authors:  P K Vaz; J Horsington; C A Hartley; G F Browning; N P Ficorilli; M J Studdert; J R Gilkerson; J M Devlin
Journal:  J Gen Virol       Date:  2015-12-21       Impact factor: 3.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.